Kyle Barrie, PhD, is a Senior Scientist at Merck, specializing in Vaccines Analytical Research and Development. Previously, Kyle served as a Doctoral Researcher at the University of Pennsylvania School of Medicine, conducting pivotal structural-functional studies on actin cytoskeletal proteins, leading to significant breakthroughs and three high-impact publications. Kyle's diverse experience includes roles as an Analytical Research & Development Chemist at Hovione and participation in undergraduate research fellowships. With a strong foundation in both industry and academia, Kyle excels in problem-solving and mentoring while pursuing opportunities to broaden their expertise.
Location
New York City Metropolitan Area, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices